Compare Equinor ASA (EQNR) vs Herbalife Nutrition Ltd (HLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinor ASA vs Herbalife Nutrition Ltd — how do they compare? Equinor ASA trades at $43.01 (market cap $101.62B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: Equinor ASA is far larger — about 75.8× Herbalife Nutrition Ltd's market cap, and Equinor ASA pays a 3.63% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinor ASA for 59 Days and Herbalife Nutrition Ltd for 43 Days on average.
| EQNR | HLF | |
|---|---|---|
Market Cap | $101.62B | $1.34B |
Volume | 4,991,782 | 1,589,457 |
Sector | Energy | Consumer Staples |
52-Week High | $45.75 | $19.96 |
52-Week Low | $22.41 | $7.75 |
Typical Hold Time | 59 Days | 43 Days |
Enterprise Value | $110.31B | $3.18B |
Dividend Yield | 3.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinor (EQNR) trades at $42.93, up 3.17% today, with a bullish technical signal and strong valuation metrics including a P/E of 11.63 and EV/EBITDA of 2.39. Recent earnings show mixed results, beating estimates in Q4 2025 and Q1 2026 but missing in Q2 2026. The company maintains robust cash flow from operations at $20.0 billion in 2025 and has announced dividends and share buy-backs, reflecting financial health.
The outlook is positive with a consensus price target of $87.50, implying significant upside. Key opportunities include LNG expansion plans and cost efficiency, while risks involve volatile energy prices and execution challenges. Analyst sentiment is mixed but leans bullish, supported by strong institutional interest and strategic growth initiatives.
HLF trades at $12.82, up 1.34% today, with a bullish technical signal from moving averages and oscillators. The company reported mixed quarterly earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026. Revenue has been stable around $5.0B annually, with a net income margin of 4.53% in 2025. Recent news includes a $250 million share repurchase program and a planned CEO transition effective October 31, 2026.
The stock appears undervalued with a P/E of 8.22 and P/S of 0.26, supported by a 53.84% analyst buy rating and a $19.00 consensus price target. Key risks include high debt levels, with total liabilities at $3.53B, and inconsistent earnings performance. Positive cash flow trends in 2026 projections and margin expansion plans offer potential upside, but investor caution is warranted due to ongoing leadership changes and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →About Herbalife Nutrition Ltd
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →
